Palantir stock has had a rough stretch. A 5-star Wall Street analyst just said the market is reading the company wrong.

UBS analyst Karl Keirstead raised his price target on Palantir Technologies to $250 from $220 on Sept. 15, reiterating his Buy rating, according to CNBC. At Palantir’s Sept. 14 closing price of roughly $173, the new target implies about 44% upside.

What UBS said about Palantir after AIPCon

Keirstead’s updated view stemmed directly from Palantir’s Sept. 10 AIPCon11 event, where Palantir brought together customers, executives, and partners to discuss how companies are deploying its AI platform in real operations.

“Our view of Palantir as the best AI enabler in the market, making frontier models and AI useful in large enterprises, was, if anything, bolstered by these conversations, and demand momentum seems robust,” Keirstead wrote in a note shared with clients.

He described three points that stood out from the event. Customer conversations kept coming back to AI sovereignty, the idea that enterprises and governments want control over their own data and AI infrastructure, rather than handing it to a small number of large cloud providers.

Keirstead noted that Palantir’s platform is being used across a broadening range of industries beyond its traditional government and defense base. He also said Palantir’s AIP software is increasingly being deployed in production rather than sitting in pilot programs.

More Palantir:

On the sovereignty point, Keirstead is tracking a real shift. Enterprises that spent 2024 and early 2025 experimenting with AI tools from large cloud providers are increasingly asking who owns their data when they use those tools.

Palantir’s pitch is that its software runs on a company’s own infrastructure and keeps sensitive data under customer control. That is a meaningful selling point for government agencies, healthcare companies, and financial institutions that cannot hand sensitive operational data to a third party.

The analyst also pointed to Palantir’s second-quarter results as evidence that momentum is real. The company posted $3.4 billion in bookings for the quarter and a net dollar retention rate of 157%, CNBC reported. A net dollar retention rate above 100% means existing customers are spending more over time, not just renewing at the same level.

The $250 target is the third upward revision UBS has made on Palantir this year. The firm started at $200 in June, moved to $220 in August and now sits at $250 in September.

UBS is not alone in this trend. D.A. Davidson raised its own target to $250 from $200 last week following the same AIPCon11 event, as TheStreet reported.

Why Palantir’s valuation is still a debate on Wall Street

The bullish case from UBS runs against the broader analyst consensus on Palantir. The average price target across Wall Street sits around $194, well below UBS’s $250, and the overall rating lands at Moderate Buy. Some analysts remain cautious on the valuation, even as they acknowledge the company’s strong execution.

The stock has been under pressure for most of 2026. Concerns about valuation have weighed on it, even as the company continues to deliver strong quarterly results. Keirstead’s note makes the case that the sell-off has created an entry point.

His valuation argument is that Palantir looks cheaper than it appears when compared to other high-growth software companies. He named Snowflake and CrowdStrike as peers compared to which Palantir’s growth profile looks attractive, even though its absolute valuation remains elevated.

The bullish case from UBS runs against the broader analyst consensus on Palantir.

Bloomberg / Getty Images

What Palantir’s guidance upgrade means for the stock

The company raised its full-year 2026 revenue guidance by roughly $500 million following its second-quarter results. The new range sits at $8.15 billion to $8.16 billion, as TheStreet reported.

That kind of guidance increase is one reason UBS is pushing its target higher, but it also sets a high bar for the company to clear when it reports third-quarter results in early November.

CEO Alex Karp has projected $15 billion to $18 billion in free cash flow over the next two years, CryptoBriefing noted. That is an ambitious forecast for a company whose stock is already pricing in significant growth.

If those figures hold up, the current valuation looks more reasonable. If they miss, the stock has a long way to fall, given where it is priced.

Palantir also secured a $127 million slice of a $192 million U.S. Army TITAN defense contract as prime contractor this year, as TheStreet reported, adding to its government revenue base.

Defense contracts provide durable, long-term revenue that commercial AI work cannot always match for predictability. Having both legs of the business grow at the same time is a key reason UBS is more optimistic than the average analyst on the street.

What investors should watch on Palantir from here

Keirstead’s thesis rests on a few things going right.

  1. Commercial customer growth needs to keep expanding beyond the government and defense contracts that built Palantir’s reputation.
  2. Bookings need to hold at the level that Q2 set.
  3. The company needs to keep converting AI pilots into full production deployments with paying customers at scale.

The sovereign AI theme is real. Enterprises in healthcare, manufacturing, and financial services are increasingly asking who controls their AI models and data, and Palantir’s pitch is that it gives them that control.

If that concern keeps growing, it could drive demand well beyond Palantir’s current customer base.

The risk is valuation. A 44% price target implies a lot of continued execution at a pace that Palantir has delivered recently but that the market is still debating whether it can sustain. Any slowdown in bookings, commercial growth or AI enterprise spending could hit the stock hard at these levels.

Keirstead is betting it does not slow down. Most other analysts are less certain.

Keirstead is a 5-star analyst on TipRanks, ranked among the top 600 out of more than 12,000 analysts tracked on the platform, according to TipRanks.

His Palantir calls have been directionally correct this year. He has raised his Palantir target three times in 2026.

The Q3 earnings report in early November will be the next big test of whether the momentum he saw at AIPCon11 is showing up in the numbers.

Related: Veteran analyst resets Palantir price target for rest of 2026